176 related articles for article (PubMed ID: 18715886)
21. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
Kaiser J
Science; 2005 Jun; 308(5729):1735-6. PubMed ID: 15961648
[No Abstract] [Full Text] [Related]
22. Radiation and primary response to lipopolysaccharide: bone marrow-derived cells and susceptible organs.
Gridley DS; Miller GM; Pecaut MJ
In Vivo; 2007; 21(3):453-61. PubMed ID: 17591354
[TBL] [Abstract][Full Text] [Related]
23. Acute and repeated dose toxicity studies of recombinant saxatilin, a disintegrin from the Korean snake (Gloydius saxatilis).
Sohn YD; Hong SY; Cho KS; Choi WS; Song SW; Bae JS; Kim DS; Chung KH
Toxicon; 2008 Mar; 51(3):406-17. PubMed ID: 18155118
[TBL] [Abstract][Full Text] [Related]
24. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
25. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
Kaufmann KB; Brendel C; Suerth JD; Mueller-Kuller U; Chen-Wichmann L; Schwäble J; Pahujani S; Kunkel H; Schambach A; Baum C; Grez M
Mol Ther; 2013 Mar; 21(3):648-61. PubMed ID: 23207695
[TBL] [Abstract][Full Text] [Related]
26. Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.
Sgura A; De Amicis A; Stronati L; Cinelli S; Pacchierotti F; Tanzarella C
Environ Mol Mutagen; 2008 Jul; 49(6):467-75. PubMed ID: 18481314
[TBL] [Abstract][Full Text] [Related]
27. Insertional mutagenesis and clonal dominance: biological and statistical considerations.
Fehse B; Roeder I
Gene Ther; 2008 Jan; 15(2):143-53. PubMed ID: 17972922
[TBL] [Abstract][Full Text] [Related]
28. [Breakthrough in gene therapy? Interview by Friederike Klein].
Grez M
MMW Fortschr Med; 2006 Apr; 148(17):16. PubMed ID: 16711482
[No Abstract] [Full Text] [Related]
29. [Toxicological assessment on safety of water and 70% ethanolic extracts of nearly ripe fruit of Evodia rutaecarpa].
Yang XW
Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(11):1317-21. PubMed ID: 18831217
[TBL] [Abstract][Full Text] [Related]
30. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.
Wolach B; Gavrieli R; de Boer M; Gottesman G; Ben-Ari J; Rottem M; Schlesinger Y; Grisaru-Soen G; Etzioni A; Roos D
Clin Immunol; 2008 Oct; 129(1):103-14. PubMed ID: 18708296
[TBL] [Abstract][Full Text] [Related]
31. [Studies on gene mutation and micronucleus formation induced by ethylnitrosourea (ENU) in transgenic mice in vivo].
Cao J; Yin M; Chen J; Xu S
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Jan; 34(1):28-30. PubMed ID: 11860893
[TBL] [Abstract][Full Text] [Related]
32. Murine hematopoietic stem cell transduction using retroviral vectors.
Modlich U; Schambach A; Li Z; Schiedlmeier B
Methods Mol Biol; 2009; 506():23-31. PubMed ID: 19110617
[TBL] [Abstract][Full Text] [Related]
33. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
[TBL] [Abstract][Full Text] [Related]
34. Vanadium pentoxide inhalation provokes germinal center hyperplasia and suppressed humoral immune responses.
Pinon-Zarate G; Rodriguez-Lara V; Rojas-Lemus M; Martinez-Pedraza M; Gonzalez-Villalva A; Mussali-Galante P; Fortoul TI; Barquet A; Masso F; Montano LF
J Immunotoxicol; 2008 Apr; 5(2):115-22. PubMed ID: 18569380
[TBL] [Abstract][Full Text] [Related]
35. Is retroviral gene marking too dangerous to use?
Brenner MK; Heslop HE
Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
[No Abstract] [Full Text] [Related]
36. Cytological characterization of murine bone marrow and spleen hematopoietic compartments for improved assessment of toxicity in preclinical gene marking models.
Yang M; Büsche G; Ganser A; Li Z
Ann Hematol; 2013 May; 92(5):595-604. PubMed ID: 23307598
[TBL] [Abstract][Full Text] [Related]
37. Retroviral-mediated gene transfer and nonmyeloablative conditioning: studies in a murine X-linked chronic granulomatous disease model.
Goebel WS; Dinauer MC
J Pediatr Hematol Oncol; 2002 Dec; 24(9):787-90. PubMed ID: 12468930
[TBL] [Abstract][Full Text] [Related]
38. Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.
Kang HJ; Bartholomae CC; Paruzynski A; Arens A; Kim S; Yu SS; Hong Y; Joo CW; Yoon NK; Rhim JW; Kim JG; Von Kalle C; Schmidt M; Kim S; Ahn HS
Mol Ther; 2011 Nov; 19(11):2092-101. PubMed ID: 21878903
[TBL] [Abstract][Full Text] [Related]
39. Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model.
Catley L; Hideshima T; Chauhan D; Neri P; Tassone P; Bronson R; Song W; Tai YT; Munshi NC; Anderson KC
Exp Hematol; 2007 Jul; 35(7):1038-46. PubMed ID: 17588472
[TBL] [Abstract][Full Text] [Related]
40. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
